Found 83 matching trials
A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC) PHASE4 This is an efficacy and safety study to compare aprepitant with ondansetron...
Show More Location
Multiple Locations
Learn More & Join Trial
Aprepitant as Antiemetic Prophylaxis in Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy PHASE2 Chemotherapy induced nausea and vomiting (CINV) is a major adverse effect o...
Show More Location
Princess Margaret Hospital
Learn More & Join Trial
Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast Cancer PHASE1 RATIONALE: Antiemetic drugs, such as aprepitant, may help lessen or prevent...
Show More Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Learn More & Join Trial
Comparative Study of Fosaprepitant and Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Caner Patients NA Children aged 2-12 years scheduled to receive moderately or highly emetogen...
Show More Location
Shanghai Children's Medical Center
Learn More & Join Trial
Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer PHASE2 Cisplatin is one of the most emetogenic drugs used in clinical practice and...
Show More Location
Hallym University Sacred Heart Hospital
Learn More & Join Trial
Olanzapine or Dexamethasone, With 5-HT3 RA and NK-1 RA, to Prevent CINV PHASE3 Chemotherapy-induced nausea and vomiting is a common side effect of cancer ...
Show More Location
Fifth Affilliated Hospital of Sun Yat-sen University
Learn More & Join Trial
Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer NA RATIONALE: Antiemetic drugs, such as aprepitant and ondansetron, may help l...
Show More Location
Multiple Locations
Learn More & Join Trial
Aprepitant for Prevention of Acute and Delayed Nausea and Vomiting in Patients Receiving a High-emetogenic Dose of Cyclophosphamide for Peripheral Blood Stem Cells Harvesting PHASE3 Title of the study Aprepitant for prevention of acute and delayed nausea an...
Show More Location
Azienda Ospedaliera di Perugia - Hematology dept.
Learn More & Join Trial
A Study to Investigate the Safety and Tolerability of MK-0517 in Healthy Subjects (MK-0517-012) PHASE1 This 5-part study will evaluate the safety, tolerability, and pharmacokinet...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Aprepitant / Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in Colorectal Cancer Patients - SENRI Trial NA The object of this study is to evaluate the superiority of aprepitant thera...
Show More Location
Kansai Rosai Hospital
Learn More & Join Trial